The Patent Finder

Oasmia Pharmaceutical AB

Also on record
Records under this name other than the patents Oasmia Pharmaceutical AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Oasmia Pharmaceutical AB

PatentTitleStatus Expires Confidence
US RE49,741Drug Delivery System for Administration of Poorly Water Soluble Pharmaceutically Active Substances
Formerly held
In force
 · Low confidence
In forceLow confidence
US RE49,742Drug Delivery System for Administration of Poorly Water Soluble Pharmaceutically Active Substances
Formerly held
In force
 · Low confidence
In forceLow confidence
US 10,138,204Method for producing N-retinoylcysteic acid alkyl ester
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,322,996Method for producing N-retinoylcysteic acid alkyl ester
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,765,173Drug Delivery System for Administration of a Water Soluble, Cationic and Amphiphilic Pharmaceutically Active Substance
Lapsed on the fee record
Ended Jul 1, 2026 · High confidence
Lapsed on the fee recordEnded Jul 1, 2026High confidence
US 9,974,776Estrogen receptor beta agonists for use in treating mesothelioma
Lapsed on the fee record
Ended May 22, 2026 · From the USPTO record
Lapsed on the fee recordEnded May 22, 2026From the USPTO record
US 8,367,665Estrogen receptor ligands
Lapsed on the fee record
Ended Feb 5, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 5, 2025From the USPTO record
US 9,993,438Drug Delivery System for Administration of Poorly Water Soluble Pharmaceutically Active Substances
Formerly held
Surrendered on reissue
Surrendered on reissue Dec 5, 2023 · High confidence
Surrendered on reissueSurrendered on reissue Dec 5, 2023High confidence
US 6,699,851Cytotoxic compounds and their use
Term ended
Term ended May 6, 2023 · From the USPTO record
Term endedTerm ended May 6, 2023From the USPTO record
US 7,030,158Therapeutic compounds
Formerly held
Term ended
Term ended Apr 11, 2023 · From the USPTO record
Term endedTerm ended Apr 11, 2023From the USPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited